FDA
approval
· 2023-01-13
FDA Approved: RESTORIL — Supplemental Application (SpecGx LLC)
Summary
The FDA approved a supplemental application for RESTORIL (temazepam) submitted by SpecGx LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RESTORIL (TEMAZEPAM)